Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Piriton 2mg/5ml syrup
0304010G0BCACAB
|
Piriton | Chlorphenamine maleate | Respiratory System | 10,738 |
|
Atrovent 20micrograms/dose inhaler CFC free
0301020I0BBAJAN
|
Atrovent | Ipratropium bromide | Respiratory System | 10,281 |
|
Fluticasone furoate 92microg/Vilanterol 22microg/dose
0302000V0AAABAB
|
Fluticasone furoate/vilanterol | Fluticasone furoate/vilanterol | Respiratory System | 10,228 |
|
Budesonide 400mcg/dose /Formoterol 12mcg/dose dry powder inh
0302000K0AAAUAU
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 10,112 |
|
Tiogiva 18microgram inhalation powder capsules with device
0301020Q0BEAAAA
|
Tiogiva | Tiotropium bromide | Respiratory System | 10,054 |
|
Loratadine 5mg/5ml oral solution sugar free
0304010D0AAAFAF
|
Loratadine | Loratadine | Respiratory System | 9,970 |
|
Flixotide 50micrograms/dose Evohaler
0302000N0BBBBBH
|
Flixotide | Fluticasone propionate (Inhalation) | Respiratory System | 9,919 |
|
Beclometasone 200microg/Formoterol 6microg/dose inh CFC free
0302000C0AABZBZ
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 9,592 |
|
Ciclesonide 160micrograms/dose inhaler CFC free
0302000U0AAABAB
|
Ciclesonide | Ciclesonide | Respiratory System | 9,548 |
|
Fobumix Easyhaler 320microg/dose / 9microg/dose dry pdr inh
0302000K0BIAAAU
|
Fobumix | Budesonide | Respiratory System | 9,374 |
|
Fluticasone propionate 250microg/Salmeterol 50microg/dose
0302000N0AAAYAY
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 9,209 |
|
Codeine 15mg/5ml linctus
0309010C0AAAAAA
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | 9,126 |
|
Umeclidinium brom 65microg/Vilanterol 22microg/dose dry pdr
0301040W0AAAAAA
|
Umeclidinium bromide/vilanterol | Umeclidinium bromide/vilanterol | Respiratory System | 9,091 |
|
Formoterol Easyhaler 12micrograms/dose dry powder inhaler
0301011E0BEAAAC
|
Formoterol Easyhaler | Formoterol fumarate | Respiratory System | 8,751 |
|
Salbutamol 100micrograms/dose dry powder inhaler
0301011R0AABZBZ
|
Salbutamol | Salbutamol | Respiratory System | 8,647 |
|
Budesonide 200micrograms/dose dry powder inhaler
0302000K0AAAGAG
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 8,328 |
|
Fluticasone 250micrograms/dose inhaler CFC free
0302000N0AABCBC
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 8,161 |
|
Flixotide 100micrograms/dose Accuhaler
0302000N0BBASAS
|
Flixotide | Fluticasone propionate (Inhalation) | Respiratory System | 7,631 |
|
Glycopyrronium bromide 55microg inhalation pdr caps with dev
0301020S0AAAAAA
|
Glycopyrronium bromide (Inhalation) | Glycopyrronium bromide | Respiratory System | 7,530 |
|
Flixotide 125micrograms/dose Evohaler
0302000N0BBAYBA
|
Flixotide | Fluticasone propionate (Inhalation) | Respiratory System | 7,198 |
|
Aclidinium bromide 375micrograms/dose dry powder inhaler
0301020R0AAAAAA
|
Aclidinium bromide (Inhalation) | Aclidinium bromide | Respiratory System | 7,196 |
|
Ventolin 2.5mg Nebules
0301011R0BEANAX
|
Ventolin | Salbutamol | Respiratory System | 7,179 |
|
Qvar 50 Autohaler
0302000C0BJACBG
|
Qvar | Beclometasone dipropionate | Respiratory System | 7,147 |
|
Beclometasone 200microg/Formoterol 6microg/dose dry pdr inh
0302000C0AACACA
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 6,988 |
|
Fluticasone propionate 100microg/Salmeterol 50microg/dose
0302000N0AAAXAX
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 6,584 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.